REPH - Recro Pharma, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - REPH (1588972)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
36 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P12+2+9+7-3
S24+3+6+7+14

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

A
2017-02-17
REPHScp Vitalife Partners II LP10%S - Sale$7.59-9,9832,292,8390%-$75,791-1-1-1
AM
2017-03-14
REPHScp Vitalife Partners II LP10%S - Sale$8.00-44,9772,247,862-2%-$359,992-1-1-1
AM
2017-02-14
REPHScp Vitalife Partners II LP10%S - Sale$7.89-12,0652,302,822-1%-$95,171-1-1-1
M
2017-03-14
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$8.00-15,023751,093-2%-$120,243+1-5+3
M
2017-03-14
REPHScp Vitalife Partners II LP10%S - Sale$8.00-44,9772,247,922-2%-$359,992+1-5+3
2017-02-17
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$7.59-3,334766,1160%-$25,312-4+2-1
2017-02-17
REPHScp Vitalife Partners II LP10%S - Sale$7.59-9,9832,292,8990%-$75,791-4+2-1
M
2017-02-14
REPHScp Vitalife Partners II LP10%S - Sale$7.89-12,0652,302,882-1%-$95,171-1-6+2
M
2017-02-14
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$7.89-4,030769,450-1%-$31,789-1-6+2
2017-02-13
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$7.97-2,651773,4800%-$21,130-1-6+1
2017-02-13
REPHScp Vitalife Partners II LP10%S - Sale$7.97-7,9372,314,8870%-$63,261-1-6+1
M
2016-12-15
REPHWeisman WayneDirP - Purchase$6.55+7,0007,000New+$45,830+5+40
2016-12-16
REPHFlynn KarenDirP - Purchase$6.71+800800New+$5,364+5+40
2016-12-15
REPHAltomari AlfredDirP - Purchase$6.55+1,5001,500New+$9,825+4+17+7
2016-12-13
REPHBroadfin Healthcare Master Fund Ltd10%P - Purchase$6.00+650,0003,100,086+27%+$3,900,000+1+10+10
2016-08-16
REPHBroadfin Healthcare Master Fund Ltd10%P - Purchase$7.50+390,0002,450,086+19%+$2,925,000-1+14+8-8
2016-05-31
REPHGraff FredChief Commercial OfficerP - Purchase$8.46+8,0008,000New+$67,7070+1-6+3
M
2016-05-26
REPHMcCallum StewartChief Medical OfficerP - Purchase$8.22+1,2501,250New+$10,275+4+5-1-4
2016-05-23
REPHScp Vitalife Partners II LP10%S - Sale$6.30-7,4972,322,8240%-$47,232+10+18+13+21
2016-05-23
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$6.30-2,503776,1310%-$15,769+10+18+13+21
2016-05-23
REPHMack RandallSVP, DevelopmentP - Purchase$6.30+2,0002,000New+$12,600+10+18+13+21
M
2015-11-23
REPHWeisman WayneDirS - Sale$7.91-58,3315,458,016-1%-$461,392+10+27+24+37
M
2015-11-23
REPHLudomirski AbrahamDirS - Sale$7.91-58,3315,458,016-1%-$461,392+10+27+24+37
M
2015-11-23
REPHChurchill Winston JDirS - Sale$7.91-58,3315,458,016-1%-$461,392+10+27+24+37
M
2016-05-19
REPHScp Vitalife Partners II LP10%S - Sale$6.46-18,7402,330,321-1%-$120,967+10+27+24+37
M
2016-05-19
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$6.46-6,260778,634-1%-$40,408+10+27+24+37
2016-05-19
REPHNichols DonnaCAO, ControllerP - Purchase$6.48+1,1402,340+95%+$7,387+1+28+25+38
2015-11-30
REPHScp Vitalife Partners II LP10%S - Sale$9.00-4502,349,0610%-$4,050+4-1+1-7
2015-11-30
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$9.00-150784,8940%-$1,350+4-1+1-7
M
2015-11-25
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$9.00-3,803785,0440%-$34,229-1-20-7
M
2015-11-25
REPHScp Vitalife Partners II LP10%S - Sale$9.00-11,3852,349,5110%-$102,471-1-20-7
M
2015-11-23
REPHScp Vitalife Partners II LP10%S - Sale$9.00-13,1502,360,896-1%-$118,372+1+7+3-9
M
2015-11-23
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$9.00-4,393788,847-1%-$39,544+1+7+3-9
2015-07-07
REPHBroadfin Healthcare Master Fund Ltd10%P - Purchase$11.60+646,5532,060,086+46%+$7,500,015+1+12-11-35
M
2015-06-05
REPHHenwood GeraldinePres, CEOP - Purchase$8.92+4,500104,500+5%+$40,137-30+20-21
2015-06-05
REPHGarner CharlesCFO, Chief Business OfficerP - Purchase$8.50+2,0005,000+67%+$17,000-30+20-21

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top